microRNA‐431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma

BACKGROUND. Adrenocortical carcinoma (ACC) is a rare endocrine cancer with treatments limited in efficacy for metastatic disease. New molecular targeted therapies have yet to improve patient outcomes. In contrast, established treatment regimens of adrenolytics and chemotherapy have demonstrated trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kwok, Grace T.Y., Zhao, Jing Ting, Glover, Anthony R., Gill, Anthony J., Clifton‐Bligh, Roderick, Robinson, Bruce G., Ip, Julian C.Y., Sidhu, Stan B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656493/
https://ncbi.nlm.nih.gov/pubmed/30918109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados